In Vitro Determination of Hydrolytic Enzymes and Echinocandin Susceptibility in Mexican Clinical Isolates of Candida glabrata Sensu Stricto

被引:0
|
作者
Trevino-Rangel, Rogelio de J. [1 ]
Espinosa-Perez, Jose F. [1 ]
Villanueva-Lozano, Hiram [1 ]
Soto-Quintana, Laura A. [1 ]
Montoya, Alexandra M. [1 ]
Luna-Rodriguez, Carolina E. [1 ]
Gonzalez, Gloria M. [1 ]
机构
[1] Univ Autonoma Nuevo Leon, Fac Med, Dept Microbiol, Monterrey, Nuevo Leon, Mexico
关键词
Candida glabrata; Phospholipases; Aspartyl Proteinases; Esterases; Hemolysins; Echinocandins; VIRULENCE FACTORS; ANTIFUNGAL SUSCEPTIBILITY; PHOSPHOLIPASE; PROTEINASE; HEMOLYSIN; BRACARENSIS; EXPRESSION; COAGULASE; ESTERASE; EXHIBIT;
D O I
10.5812/jjm.85092
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Background: Candida glabrata is an opportunistic yeast that has emerged as a cause of human fungal disease, and is a complex of three closely related species. Until now, there is not enough information about its virulence attributes. Moreover, its resistance to echinocandins has been documented, which is a cause of clinical concern. Objectives: The objective of this study was to evaluate the in vitro production of aspartyl proteinase, phospholipase, esterase, hemolysin, DNase, and coagulase in a subset of 107 Mexican clinical isolates of C. glabrata sensu stricto, as well as to determinate its echinocandin susceptibility. Methods: The enzymatic determinations were carried out in plate assays using specific substrates, excepting coagulase, which was determined by the classic tube test. Antifungal susceptibility testing was determined in accordance with the CLSI broth microdilution method. Results: Aspartyl proteinase, hemolysin, and phospholipase were detected in 100%, 95%, and 79% of isolates, respectively. Blood isolates were associated with a very strong activity of aspartyl proteinase and hemolysin, and those recovered from vaginal swabs were associated with very strong production of aspartyl proteinase, phospholipase, and hemolysin. All isolates were susceptible to echinocandins, except one bloodstream isolate, which was resistant to echinocandins. Conclusions: A very strong activity of aspartyl proteinase and hemolysin was particularly associated with both, bloodstream, and vaginal swab isolates. Echinocandin resistance was rare.
引用
收藏
页数:6
相关论文
共 50 条
  • [31] In vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility
    Cota, Jason
    Carden, Michael
    Graybill, John R.
    Najvar, Laura K.
    Burgess, David S.
    Wiederhold, Nathan P.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2006, 50 (11) : 3926 - 3928
  • [32] Genotypic, proteomic, and phenotypic approaches to decipher the response to caspofungin and calcineurin inhibitors in clinical isolates of echinocandin-resistant Candida glabrata
    Ceballos-Garzon, Andres
    Monteoliva, Lucia
    Gil, Concha
    Alvarez-Moreno, Carlos
    Vega-Vela, Nelson E.
    Engelthaler, David M.
    Bowers, Jolene
    Le Pape, Patrice
    Parra-Giraldo, Claudia M.
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2022, 77 (03) : 585 - 597
  • [33] Optimizing Echinocandin Dosing and Susceptibility Breakpoint Determination via In Vivo Pharmacodynamic Evaluation against Candida glabrata with and without fks Mutations
    Lepak, Alexander
    Castanheira, Mariana
    Diekema, Daniel
    Pfaller, Michael
    Andes, David
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (11) : 5875 - 5882
  • [34] Determination of Antifungal Susceptibility Patterns Among the Clinical Isolates of Candida Species
    Zomorodian, Kamiar
    Rahimi, Mohammad Javad
    Pakshir, Kayvan
    Motamedi, Marjan
    Ghiasi, Moosa Rahimi
    Rezashah, Hasanein
    JOURNAL OF GLOBAL INFECTIOUS DISEASES, 2011, 3 (04) : 357 - 360
  • [35] Effect of pH on In Vitro Susceptibility of Candida glabrata and Candida albicans to 11 Antifungal Agents and Implications for Clinical Use
    Danby, Claire S.
    Boikov, Dina
    Rautemaa-Richardson, Rina
    Sobel, Jack D.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (03) : 1403 - 1406
  • [36] Drug susceptibility profile of Candida glabrata clinical isolates from Iran and genetic resistant mechanisms to caspofungin
    Amanloo, Saeid
    Shams-Ghahfarokhi, Masoomeh
    Ghahri, Mohammad
    Razzaghi-Abyaneh, Mehdi
    REVISTA IBEROAMERICANA DE MICOLOGIA, 2018, 35 (02): : 88 - 91
  • [37] Correction: Whole genome analysis of echinocandin non-susceptible Candida Glabrata clinical isolates: a multi-center study in China
    Yi Li
    Xin Hou
    Ruoyu Li
    Kang Liao
    Ling Ma
    Xiaoming Wang
    Ping Ji
    Haishen Kong
    Yun Xia
    Hui Ding
    Wei Kang
    Ge Zhang
    Jin Li
    Meng Xiao
    Yingxing Li
    Yingchun Xu
    BMC Microbiology, 23 (1)
  • [38] Clinical characteristics of the first cases of invasive candidiasis in China due to pan-echinocandin-resistant Candida tropicalis and Candida glabrata isolates with delineation of their resistance mechanisms
    Xiao, Meng
    Fan, Xin
    Hou, Xin
    Chen, Sharon C. A.
    Wang, He
    Kong, Fanrong
    Sun, Zi-Yong
    Chu, Yun-Zhuo
    Xu, Ying-Chun
    INFECTION AND DRUG RESISTANCE, 2018, 11 : 155 - 161
  • [39] β-Aescin at subinhibitory concentration (sub-MIC) enhances susceptibility of Candida glabrata clinical isolates to nystatin
    Franiczek, Roman
    Glensk, Michal
    Krzyzanowska, Barbara
    Wlodarczyk, Maciej
    MEDICAL MYCOLOGY, 2015, 53 (08) : 845 - 851
  • [40] Comparison of Microdilution and Disk Diffusion Methods for the Detection of Fluconazole and Voriconazole Susceptibility Against Clinical Candida glabrata Isolates and Determination of Changing Susceptibility with New CLSI Breakpoints
    Hazirolan, Gulsen
    Saribas, Zeynep
    Arikan Akdagli, Sevtap
    MIKROBIYOLOJI BULTENI, 2016, 50 (03): : 428 - 437